These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38190109)

  • 1. Epstein-Barr Virus: Human Interactome Reveals New Molecular Insights into Viral Pathogenesis for Potential Therapeutics and Antiviral Drug Discovery.
    Krishnan D; Babu S; Raju R; Veettil MV; Prasad TSK; Abhinand CS
    OMICS; 2024 Jan; 28(1):32-44. PubMed ID: 38190109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents.
    Li X; Akinyemi IA; You JK; Rezaei MA; Li C; McIntosh MT; Del Poeta M; Bhaduri-McIntosh S
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analyses of Intraviral Epstein-Barr Virus Protein-Protein Interactions Hint Central Role of BLRF2 in the Tegument Network.
    Hara Y; Watanabe T; Yoshida M; Masud HMAA; Kato H; Kondo T; Suzuki R; Kurose S; Uddin MK; Arata M; Miyagi S; Yanagi Y; Sato Y; Kimura H; Murata T
    J Virol; 2022 Jul; 96(14):e0051822. PubMed ID: 35862711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections.
    Malik-Soni N; Frappier L
    J Virol; 2012 Jun; 86(12):6999-7002. PubMed ID: 22496234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug targets in herpes simplex and Epstein Barr Virus infections.
    Billaud G; Thouvenot D; Morfin F
    Infect Disord Drug Targets; 2009 Apr; 9(2):117-25. PubMed ID: 19275700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramide promotes lytic reactivation of Epstein-Barr virus in gastric carcinoma.
    Kim JY; Min YJ; Lee M-H; An YR; Ashktorab H; Smoot DT; Kwon SW; Lee SK
    J Virol; 2024 Feb; 98(2):e0177623. PubMed ID: 38197630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
    Zhang J; Jia L; Tsang CM; Tsao SW
    Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of Human and Viral miRNAs in Epstein-Barr Virus-Associated Tumors and Implications for Drug Repurposing.
    Thakur A; Kumar M
    OMICS; 2023 Mar; 27(3):93-108. PubMed ID: 36927073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors.
    Kerr JR
    J Clin Pathol; 2019 Oct; 72(10):651-658. PubMed ID: 31315893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus.
    Bouvet M; Voigt S; Tagawa T; Albanese M; Chen YA; Chen Y; Fachko DN; Pich D; Göbel C; Skalsky RL; Hammerschmidt W
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating genetic-and-epigenetic networks, and the cellular mechanisms occurring in Epstein-Barr virus-infected human B lymphocytes via big data mining and genome-wide two-sided NGS data identification.
    Li CW; Jheng BR; Chen BS
    PLoS One; 2018; 13(8):e0202537. PubMed ID: 30133498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
    Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
    Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral Replication.
    Li Y; Long X; Huang L; Yang M; Yuan Y; Wang Y; Delecluse HJ; Kuang E
    J Virol; 2016 Jan; 90(2):887-903. PubMed ID: 26537683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication.
    Lyons DE; Yu KP; Vander Heiden JA; Heston L; Dittmer DP; El-Guindy A; Miller G
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus co-opts TFIIH component XPB to specifically activate essential viral lytic promoters.
    Verma D; Church TM; Swaminathan S
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13044-13055. PubMed ID: 32434920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular RNA Helicase DHX9 Interacts with the Essential Epstein-Barr Virus (EBV) Protein SM and Restricts EBV Lytic Replication.
    Fu W; Verma D; Burton A; Swaminathan S
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30541834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers.
    Jiang L; Xie C; Lung HL; Lo KW; Law GL; Mak NK; Wong KL
    Theranostics; 2018; 8(19):5307-5319. PubMed ID: 30555548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ATM in the formation of the replication compartment during lytic replication of Epstein-Barr virus in nasopharyngeal epithelial cells.
    Hau PM; Deng W; Jia L; Yang J; Tsurumi T; Chiang AK; Huen MS; Tsao SW
    J Virol; 2015 Jan; 89(1):652-68. PubMed ID: 25355892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic Activation of Lytic Epstein-Barr Virus Gene Expression without Virion Production.
    Lee J; Kosowicz JG; Hayward SD; Desai P; Stone J; Lee JM; Liu JO; Ambinder RF
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells.
    Fu Q; He C; Mao ZR
    J Zhejiang Univ Sci B; 2013 Jan; 14(1):8-24. PubMed ID: 23303627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.